A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists (NCT06033950)
A Randomized, Double-blind, Placebo-controlled Pragmatic Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure and Reduced Ejection Fraction Who Are Intolerant of or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists (FINALITY-HF)
🩺 Plain-English Summary (8th-Grade Level)
Finerenone will be compared to placebo to determine efficacy and safety of treatment in patients with heart failure and reduced ejection fraction (HFrEF) who are intolerant or ineligible to receive treatment with steroidal mineralocorticoid receptor antagonists (sMRA).
Who can join: Review the eligibility criteria below.
Location: FIN-10004 Fairhope, AL Investigational Site — Fairhope, Alabama
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (176 Sites)
Showing the first 25 of 176 sites.
- FIN-10004 Fairhope, AL Investigational Site — Fairhope, Alabama
- Phoenix, AZ Investigative Site FIN-10115 — Phoenix, Arizona
- FIN-10401, Yuma, AZ — Yuma, Arizona
- Chula Vista, CA Investigative Site FIN-10419 — Chula Vista, California
- Chula Vista, CA Investigative Site FIN-10111 — Chula Vista, California
- FIN-10407, Northridge, CA — Northridge, California
- FIN-10412, Orange, CA — Orange, California
- FIN-10070, Pamona, CA — Pomona, California
- FIN-10024, Sacramento, CA — Sacramento, California
- FIN-10406, San Diego, CA — San Diego, California
- San Diego, CA Investigative Site FIN-10420 — San Diego, California
- FIN-10075 San Diego, CA Investigational Site — San Diego, California
- San Francisco, CA Investigative Site FIN-10023 — San Francisco, California
- FIN-10423, Sherman Oaks, CA — Sherman Oaks, California
- FON-10409, Tarzana, CA — Tarzana, California
- FIN-10109, Van Nuys, CA — Van Nuys, California
- FIN-10408, West Covina, CA — West Covina, California
- FIN-10013, West Hills, CA — West Hills, California
- FIN-10110, Aurora, CO — Aurora, Colorado
- FIN-10001, Aurora, CO — Aurora, Colorado
- Bradenton, FL Investigative Site FIN-10125 — Bradenton, Florida
- FIN-10104, Hialeah, FL — Hialeah, Florida
- FIN-10028, Jacksonville, FL — Jacksonville, Florida
- FIN-10105, Miami, FL — Miami, Florida
- FIN-10113, Miramar, FL — Miramar, Florida
📞 Contact the Study Coordinator
Phone: (303) 860-9900
Email: info@cpcmed.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Heart Failure
- REDUCE LAP-HFREF TRIAL — New York, New York
- Physiological Effects Ketone Ester in Heart — Cleveland, Ohio
- DASH Diet in Heart Failure Outpatients — Sacramento, California
- Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients — Huntsville, Alabama
- LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System. — Birmingham, Alabama
- A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation — Alexander City, Alabama
Explore by condition: All Heart Failure clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.